Landmark Ruling Reinforces Safeguards for Safety-Net Providers Amid Pharmaceutical Industry Challenges In a significant development…
Alex CullorMay 27, 2025
In the current political landscape, debates around drug pricing, tax policy, and entitlement reform are…
Alex CullorMay 14, 2025
How Clarifying 340B Duplicate Discount Policies Can Strengthen Patient Access and Provider Sustainability The 340B…
Alex CullorApril 9, 2025
The 340B Drug Pricing Program is facing unprecedented pressure. A growing number of pharmaceutical manufacturers…
Alex CullorMarch 26, 2025
The 340B Drug Pricing Program has long been a lifeline for safety-net providers serving America’s…
Alex CullorMarch 26, 2025
Access to healthcare remains one of the most pressing challenges for vulnerable populations in the…
Alex CullorMarch 19, 2025
